Browse Sarafan ChEM-H | Stanford Profiles

Corey Liu

Associate Director, Nucleus Operations and Facilities Planning, Sarafan ChEM-H

Contact Info
Mail Code: 5082
- (650) 724-7445 (office)

Siavash Mashayekh

Assay Scientist, Biochemistry, Innovative Medicines Accelerator (IMA)

Contact Info
Mail Code: 5080
siavashm@stanford.edu

Rebecca McClellan

Associate Director, Research Programs and Communications, Sarafan ChEM-H

Contact Info
Mail Code: 5082
rmcclell@stanford.edu

Xiandong Meng

Bioinformatic Scientist, Microbiome Therapies Initiative (MITI)

Contact Info
Mail Code: 5082
xdmeng@stanford.edu

Tam Thuy Dan Nguyen

Senior Synthetic Microbiome Engineer, Microbiome Therapies Initiative (MITI)

Contact Info
Mail Code: 5082
ntam510@stanford.edu

Olivia N Pattelli

Structural Biology Protein Scientist, Sarafan ChEM-H

Contact Info
Mail Code: 5080
patteoli@stanford.edu

Jason Pellman

Scientific Program Manager, Innovative Medicines Accelerator (IMA)

Contact Info
Mail Code: 5082
jpellman@stanford.edu

Thi Phuong Thao Pham

Senior Synthetic Microbiome Engineer, Microbiome Therapies Initiative (MITI)

Contact Info
Mail Code: 4245
thaopham@stanford.edu

Lora K Picton

Lead Research Scientist, Protein Engineering, Innovative Medicines Accelerator (IMA)

Contact Info
Mail Code: 5082
lkpicton@stanford.edu

BioDr. Elizabeth Ponder joined Stanford ChEM-H in 2014 and is currently the Executive Director of Sarafan ChEM-H and the Stanford Innovative Medicines Accelerator (IMA). Dr. Ponder completed her Ph.D. and postdoctoral training at Stanford University in the laboratory of Dr. Matthew Bogyo. Her past work has included promoting public-private partnerships in the non-profit sector, managing multidisciplinary research in the higher education sector, and business development consulting in the for-profit biotech sector. Dr. Ponder joined ChEM-H from the University of California, Berkeley where she served as the Executive Director of the Henry Wheeler Center for Emerging & Neglected Diseases (CEND).